GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
NASDAQ:ALXN
Delisted

Alexion Pharmaceuticals Stock Price (Quote)

$182.50
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $182.50 $182.50 Friday, 27th May 2022 ALXN stock ended at $182.50. During the day the stock fluctuated 0% from a day low at $182.50 to a day high of $182.50.
90 days $182.50 $182.50
52 weeks $174.72 $187.45

Historical Alexion Pharmaceuticals prices

Date Open High Low Close Volume
2019-09-24 $105.44 $105.92 $100.16 $100.32 2 376 078
2019-09-23 $106.39 $107.00 $104.52 $104.62 1 949 802
2019-09-20 $105.15 $106.96 $104.07 $106.32 2 598 280
2019-09-19 $103.65 $106.26 $103.26 $105.67 2 216 602
2019-09-18 $106.90 $107.82 $102.17 $102.98 3 527 070
2019-09-17 $108.86 $109.24 $107.73 $107.83 1 450 230
2019-09-16 $106.66 $109.42 $106.45 $108.54 2 062 567
2019-09-13 $109.33 $109.74 $107.23 $107.40 1 891 446
2019-09-12 $110.14 $110.64 $107.91 $108.26 2 358 301
2019-09-11 $109.87 $110.37 $106.50 $108.90 1 952 522
2019-09-10 $106.02 $110.24 $106.02 $109.60 3 798 300
2019-09-09 $103.95 $106.75 $102.50 $106.40 2 493 527
2019-09-06 $100.10 $104.07 $100.10 $103.84 3 046 106
2019-09-05 $98.68 $101.64 $98.41 $100.28 2 509 607
2019-09-04 $95.95 $100.05 $95.56 $97.53 3 706 946
2019-09-03 $100.26 $100.38 $94.93 $95.18 6 286 935
2019-08-30 $103.00 $104.93 $98.94 $100.76 8 547 570
2019-08-29 $112.99 $114.21 $110.86 $112.17 1 600 056
2019-08-28 $109.53 $113.29 $109.53 $111.27 1 551 069
2019-08-27 $112.78 $113.50 $109.94 $110.16 1 790 663
2019-08-26 $112.00 $113.38 $109.60 $111.66 4 041 005
2019-08-23 $123.12 $124.02 $114.93 $115.33 5 246 754
2019-08-22 $115.16 $125.52 $112.57 $123.49 7 289 754
2019-08-21 $112.50 $114.93 $112.23 $114.84 2 556 973
2019-08-20 $112.56 $113.91 $111.40 $111.43 1 837 091
Click to get the best stock tips daily for free!

About Alexion Pharmaceuticals

Alexion Pharmaceuticals Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. It provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosp... ALXN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT